Kim Van Vliet
- Genetics top 2%
- Molecular Biology top 10%
- Cardiology and Cardiovascular Medicine top 10%
- Epidemiology
- Infectious Diseases top 10%
- Co-authors
- Mavis Agbandje‐McKennaJames M. WilsonChristie BellGeorge AslanidiBrittney L. GurdaRobert McKennaRichard O. SnyderVéronique Blouin
- Topics
- Virus-based gene therapy research (20 papers)RNA Interference and Gene Delivery (7 papers)CRISPR and Genetic Engineering (6 papers)
- Partner nations
- United StatesGermanyChina
In The Last Decade
Kim Van Vliet
23 papers receiving 1.3k citations
Peers
Comparison fields: 5 of 86
- Genetics 987
- Molecular Biology 985
- Cardiology and Cardiovascular Medicine 180
- Epidemiology 175
- Infectious Diseases 167
Countries citing papers authored by Kim Van Vliet
This map shows the geographic impact of Kim Van Vliet's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kim Van Vliet with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kim Van Vliet more than expected).
Fields of papers citing papers by Kim Van Vliet
This network shows the impact of papers produced by Kim Van Vliet. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kim Van Vliet. The network helps show where Kim Van Vliet may publish in the future.
Co-authorship network of co-authors of Kim Van Vliet
This figure shows the co-authorship network connecting the top 25 collaborators of Kim Van Vliet. A scholar is included among the top collaborators of Kim Van Vliet based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kim Van Vliet. Kim Van Vliet is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 44 | |
| 2 | 50 | |
| 3 | 69 | |
| 4 | 23 | |
| 5 | 51 | |
| 6 | 30 | |
| 7 | 41 | |
| 8 | 43 | |
| 9 | 58 | |
| 10 | 31 | |
| 11 | 140 | |
| 12 | 12 | |
| 13 | 83 | |
| 14 | 12 | |
| 15 | 21 | |
| 16 | 143 | |
| 17 | 25 | |
| 18 | 64 | |
| 19 | 86 | |
| 20 | 23 |
About Kim Van Vliet
Kim Van Vliet is a scholar working on Genetics, Animal Science and Zoology and Ecological Modeling, having authored 23 papers that have together received 1.3k indexed citations. Recurring topics across this work include Virus-based gene therapy research (20 papers), RNA Interference and Gene Delivery (7 papers) and CRISPR and Genetic Engineering (6 papers). The work is most often cited by research in Genetics (987 citations), Molecular Biology (985 citations) and Animal Science and Zoology (96 citations). Kim Van Vliet has collaborated with scholars based in United States, Germany and China. Frequent co-authors include Mavis Agbandje‐McKenna, James M. Wilson, Christie Bell, George Aslanidi, Brittney L. Gurda, Robert McKenna, Richard O. Snyder, Véronique Blouin, Barry J. Byrne and Luk H. Vandenberghe. Their work appears in journals such as Journal of Clinical Investigation, ACS Nano and PLoS ONE.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.